Wells Fargo & Company Exagen Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Exagen Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 2,457 shares of XGN stock, worth $4,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,457

Previous 2,456 0.04%

Holding current value

$4,471

Previous $4,000 25.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.42 - $2.3 $1 - $2	1 Added 0.04%	2,457 $3,000
Q4 2023 Feb 09, 2024	BUY	$1.45 - $2.39 $5 - $9	4 Added 0.16%	2,456 $4,000
Q3 2023 Nov 13, 2023	SELL	$2.24 - $2.93 $15 - $20	-7 Reduced 0.28%	2,452 $5,000
Q2 2023 Aug 15, 2023	BUY	$2.36 - $3.48 $11 - $17	5 Added 0.2%	2,459 $7,000
Q1 2023 May 12, 2023	BUY	$2.23 - $2.9 $4 - $5	2 Added 0.08%	2,454 $5,000

Q4 2022 Feb 13, 2023	BUY	$2.1 - $3.4 $2,102 - $3,403	1,001 Added 68.99%	2,452 $5,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $8.68 $3,430 - $8,680	1,000 Added 221.73%	1,451 $4,000
Q2 2022 Aug 12, 2022	SELL	$4.18 - $7.74 $15,202 - $28,150	-3,637 Reduced 88.97%	451 $2,000
Q1 2022 May 16, 2022	SELL	$7.12 - $11.06 $25,596 - $39,760	-3,595 Reduced 46.79%	4,088 $33,000
Q4 2021 Feb 14, 2022	BUY	$8.97 - $14.08 $65,445 - $102,727	7,296 Added 1885.27%	7,683 $90,000
Q2 2021 Aug 16, 2021	SELL	$12.4 - $17.92 $17,930 - $25,912	-1,446 Reduced 78.89%	387 $6,000
Q1 2021 May 13, 2021	SELL	$13.9 - $22.0 $78,131 - $123,662	-5,621 Reduced 75.41%	1,833 $32,000
Q4 2020 Feb 09, 2021	SELL	$11.19 - $16.05 $69,221 - $99,285	-6,186 Reduced 45.35%	7,454 $98,000
Q3 2020 Nov 05, 2020	SELL	$10.56 - $16.69 $6,209 - $9,813	-588 Reduced 4.13%	13,640 $148,000
Q2 2020 Aug 13, 2020	BUY	$11.0 - $16.7 $115,291 - $175,032	10,481 Added 279.72%	14,228 $177,000
Q1 2020 May 14, 2020	BUY	$12.7 - $25.95 $47,586 - $97,234	3,747 New	3,747 $60,000

Others Institutions Holding XGN

# of Institutions

Shares Held

6.21M

Call Options Held

1.6K

Put Options Held

4.1K

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $29.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Exagen Inc. Transaction History